Vimarsana
Biggest News Aggregation in the World

Hellix Investment News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hellix Investment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hellix Investment Today - Breaking & Trending Today

Concord Biotech IPO subscribed 14.23 times on day 3 so far, issue closes today - Vimarsana News

Concord Biotech IPO subscribed 14.23 times on day 3 so far, issue closes today

Published: August 8, 2023

Incorporated in 1984, Concord Biotech is a homegrown R&D driven biopharma firm among the global developers and manufacturers of select fermentation-based APIs.

Source: businesstoday.in
Related Topics:
Abu DhabiAbuz AbyUnited Arab EmiratesHellix Investment HoldingsMotilal Oswal Financial ServicesAbu Dhabi Investment AuthorityGovernment Pension Fund GlobalKotak Mahindra Capital CompanyMutual FundWf Asian Reconnaissance FundConcord BiotechHellix InvestmentPolar Capital FundsReconnaissance FundAmundi FundsReliance SecuritiesMahindra Capital CompanyCitigroup Global Markets IndiaJefferies IndiaLink Intime IndiaBusiness TodayConcord Biotech Day 3Concord Biotech Ipo Day 3Oncord Biotech Subscription Day 3Oncord Biotech Ipo Subscription Day 3
Concord Biotech IPO opens today: Should you subscribe to shield your portfolio? - Vimarsana News

Concord Biotech IPO opens today: Should you subscribe to shield your portfolio?

Published: August 4, 2023

Incorporated in 1984, Concord Biotech is a homegrown R&D driven biopharma firm among the global developers and manufacturers of select fermentation-based APIs.

Source: businesstoday.in
Related Topics:
Abu DhabiAbuz AbyUnited Arab EmiratesUnited StatesRakesh JhunjhunwalaGlenmark LifesciencesSuven PharmaAnand RathiHellix Investment HoldingsReliance IndustriesGovernment Pension Fund GlobalMutual FundAbu Dhabi Investment AuthorityWf Asian Reconnaissance FundKotak Mahindra Capital CompanyConcord BiotechHellix InvestmentMahindra Capital CompanyCitigroup Global Markets IndiaJefferies IndiaLink Intime IndiaPolar Capital FundsReconnaissance FundAmundi FundsLaurus Labs
Concord Biotech IPO subscribed 25% in first three hours; employees lead bidding process - Vimarsana News

Concord Biotech IPO subscribed 25% in first three hours; employees lead bidding process

Published: August 4, 2023

Incorporated in 1984, Concord Biotech is a homegrown R&D driven biopharma firm among the global developers and manufacturers of select fermentation-based APIs.

Source: businesstoday.in
Related Topics:
Abu DhabiAbuz AbyUnited Arab EmiratesHellix Investment HoldingsMutual FundGovernment Pension Fund GlobalKotak Mahindra Capital CompanyMotilal Oswal Financial ServicesWf Asian Reconnaissance FundAbu Dhabi Investment AuthorityConcord BiotechHellix InvestmentPolar Capital FundsReconnaissance FundAmundi FundsMahindra Capital CompanyCitigroup Global Markets IndiaJefferies IndiaLink Intime IndiaConcord Biotech Day 1Oncord Biotech Ipo Day 1Oncord Biotech Subscription Day 1Oncord Biotech Ipo Subscription Day 1Oncord Biotech Subscription StatusConcord Biotech Ipo Subscription Status